Parent Market Analysis
The CDMO market has been categorized as a part of the global specialized consumer services market within the global diversified consumer services market. Technavio's market research report extensively covers external factors influencing the parent market growth potential in the coming years to determine the growth of the CDMO market during the forecast period.
CDMO Market Highlights:
- Growth potential (2020-2025): USD 64.44 billion
- CAGR: Accelerating at 11.12%.
- Year-over-year growth: 9.45%
Looking for further highlights related to the CDMO market? Read a Sample Report Free of Cost
CDMO Market: Major regions and key countries:
- North America (US)
- Europe (UK and Germany)
- APAC (China and Japan)
- South America
- MEA
CDMO Market: Key Vendors and Their Offerings
Almac Group Ltd., Apollo 5 GmbH, Catalent Inc., FAMAR Health Care Services, FUJIFILM Holdings Corp., Lonza Group Ltd., Recipharm AB, Siegfried Holding AG, The Lubrizol Corp., and Thermo Fisher Scientific Inc. are some of the key vendors operating in the CDMO market. The key offerings of some of these vendors are mentioned below:
- Almac Group Ltd. - The company offers an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.
- Apollo 5 GmbH - The company offers development and manufacturing services for the pharmaceutical and healthcare industry.
- Catalent Inc. - The company offers CDMO integrated solutions to help life science innovators develop and launch successful pharmaceuticals, biologics, and consumer health products.
Technavio offers a comprehensive list of more than 20 vendors in the market. To explore some of these vendors, View a Free Sample
CDMO Market: Segmentation
- Product: By product, the CDMO market has been classified into small molecules and biologics segments. The small molecules segment will have significant market share growth during the forecast period. The increasing applications of small molecules for the treatment of chronic diseases, such as cancer and diabetes, will result in a rise in their demand during the forecast period.
- Geography: By geography, the CDMO market has been classified into North America, Europe, APAC, South America, and MEA. 35% of the market's growth will originate from North America during the forecast period. The US is a key market for CDMO in North America. Moreover, market growth in North America will be faster than the growth of the market in MEA and South America. The increase in the number of people with chronic diseases in countries such as the US and Canada will drive the CDMO market growth in North America during the forecast period.
Find out which segments dominate the CDMO market. Download a Free Sample Now
CDMO Market: Customization
Technavio's market forecast report on the CDMO market covers all the key aspects of market research, from the latest drivers and trends to the key vendors impacting the market growth. But if you still have queries, have all your questions answered by expert analysts at Technavio. Get in touch with us, and we will customize the report according to your requirements.
We also offer USD 1000 worth FREE customization. Speak to Our Analyst Now
Related Reports
Contract Development and Manufacturing Organization Outsourcing Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 11.12% |
Market growth 2021-2025 |
USD 64.44 billion |
Market structure |
Fragmented |
YoY growth (%) |
9.45 |
Regional analysis |
North America, Europe, APAC, South America, and MEA |
Performing market contribution |
North America at 35% |
Key consumer countries |
US, China, UK, Japan, and Germany |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Albany Molecular Research Inc., Alcami Corp., Almac Group Ltd., Apollo 5 GmbH, Boehringer Ingelheim International GmbH, Catalent Inc., Celonic AG, Corden Pharma International GmbH, Eurofins Scientific SE, FAMAR Health Care Services, FUJIFILM Holdings Corp., Lonza Group Ltd., Piramal Enterprises Ltd., Recipharm AB, Siegfried Holding AG, The Lubrizol Corp., Thermo Fisher Scientific Inc., and Vetter Pharma-Fertigung GmbH & Co. KG |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact:
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article